Sandbox Reserved 1491: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 60: Line 60:


The development of cancer begins with the modification of the sequence and expression of the genes involved in the [https://en.wikipedia.org/wiki/Cell_cycle cell cycle]. <ref>https://en.wikipedia.org/wiki/Cancer</ref>
The development of cancer begins with the modification of the sequence and expression of the genes involved in the [https://en.wikipedia.org/wiki/Cell_cycle cell cycle]. <ref>https://en.wikipedia.org/wiki/Cancer</ref>
The transformation from healthy cells to cancer cells is carried out in two stages: carcinogenesis and tumorigenesis.
The transformation from healthy cells to cancer cells is carried out in two stages: carcinogenesis and tumorigenesis.
During [https://en.wikipedia.org/wiki/Carcinogenesis  carcinogenesis], cells accumulate genetic abnormalities, particularly in [https://en.wikipedia.org/wiki/Oncogene oncogenic] sequences. Oncogenes are positive regulators of cell proliferation. After a mutation, they become hyperactive and cause an excessive cellular growth. [https://en.wikipedia.org/wiki/Caretaker_gene Gatekeeper genes] (genes that allow the passage from one stage of the cell cycle to the next) can also be mutated, leading to uncontrolled cell proliferation.
During [https://en.wikipedia.org/wiki/Carcinogenesis  carcinogenesis], cells accumulate genetic abnormalities, particularly in [https://en.wikipedia.org/wiki/Oncogene oncogenic] sequences. Oncogenes are positive regulators of cell proliferation. After a mutation, they become hyperactive and cause an excessive cellular growth. [https://en.wikipedia.org/wiki/Caretaker_gene Gatekeeper genes] (genes that allow the passage from one stage of the cell cycle to the next) can also be mutated, leading to uncontrolled cell proliferation.
During tumorigenesis, cancer becomes invasive: cancer cells invade other healthy organs.
During tumorigenesis, cancer becomes invasive: cancer cells invade other healthy organs.


KDM4C is involved in carcinogenesis as an oncogene. Indeed, by catalyzing the demethylation of H3K9-me3 (lysine 9 from trimethylated histones 3) to H3K9-me2 (lysine 9 from dimethylated histones 3), this protein increases the expression of its target genes. Several KDM4C target genes are involved in cell growth. For example, they influence mitogenic signalling - which promotes mitosis and cell division -, cell cycle regulation and translation.  
KDM4C is involved in carcinogenesis as an oncogene. Indeed, by catalyzing the demethylation of H3K9-me3 (lysine 9 from trimethylated histones 3) to H3K9-me2 (lysine 9 from dimethylated histones 3), this protein increases the expression of its target genes. Several KDM4C target genes are involved in cell growth. For example, they influence mitogenic signalling - which promotes mitosis and cell division -, cell cycle regulation and translation.  
In cancer cells, KDM4C expression is enhanced. Thus, the growth of tumor cells is greatly increased.3
In cancer cells, KDM4C expression is enhanced. Thus, the growth of tumor cells is greatly increased. <ref>Gregory, Brittany L., and Vivian G. Cheung. ‘Natural Variation in the Histone Demethylase, KDM4C, Influences Expression Levels of Specific Genes Including Those That Affect Cell Growth’. Genome Research 24, no. 1 (January 2014): 52–63. https://doi.org/10.1101/gr.156141.113</ref>
In addition, KDM4C is involved in the correct segregation of chromosomes. Its high presence in tumor cells therefore ensures their viability.4
 
 
In addition, KDM4C is involved in the correct segregation of chromosomes. Its high presence in tumor cells therefore ensures their viability.<ref>Garcia, Jeison, and Fernando Lizcano. ‘KDM4C Activity Modulates Cell Proliferation and Chromosome Segregation in Triple-Negative Breast Cancer’. Breast Cancer : Basic and Clinical Research 10 (2 November 2016): 169–75. https://doi.org/10.4137/BCBCR.S40182.</ref>
 
Finally, KDM4C also plays a role in the tumorigenesis of certain cancers, such as breast cancer, since it allows the proliferation of cancer cells, their migration and their invasive capacity in the triple-negative breast cancer.  
Finally, KDM4C also plays a role in the tumorigenesis of certain cancers, such as breast cancer, since it allows the proliferation of cancer cells, their migration and their invasive capacity in the triple-negative breast cancer.  


For all the implications of KDM4C in different cancers, it is one of the main targets of anti-cancer treatments.
For all the implications of KDM4C in different cancers, it is one of the main targets of anti-cancer treatments.